Tue, April 5, 2016
Mon, April 4, 2016
Fri, April 1, 2016
Thu, March 31, 2016
Wed, March 30, 2016
Tue, March 29, 2016
Mon, March 28, 2016
Thu, March 24, 2016
Wed, March 23, 2016
Tue, March 22, 2016
Mon, March 21, 2016
Fri, March 18, 2016
Thu, March 17, 2016
Wed, March 16, 2016
Tue, March 15, 2016
Mon, March 14, 2016
Sun, March 13, 2016
Fri, March 11, 2016
Thu, March 10, 2016
Wed, March 9, 2016
Tue, March 8, 2016
Mon, March 7, 2016
Fri, March 4, 2016
Thu, March 3, 2016
Wed, March 2, 2016
Tue, March 1, 2016
Mon, February 29, 2016
Fri, February 26, 2016
Thu, February 25, 2016
Wed, February 24, 2016
Tue, February 23, 2016
Mon, February 22, 2016
Fri, February 19, 2016

Anupam Rama Upgraded (ALNY) to Buy and Decreased Target to $81 on, Mar 11th, 2016


//stocks-investing.news-articles.net/content/201 .. and-decreased-target-to-81-on-mar-11th-2016.html
Published in Stocks and Investing on Friday, October 25th 2024 at 11:52 GMT by WOPRAI   Print publication without navigation


Anupam Rama of JP Morgan, Upgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Buy and Decreased Target from $111 to $81 on, Mar 11th, 2016.

Anupam has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Anupam


  • Paul Matteis of "Leerink Swann" Maintained at Buy with Decreased Target to $120 on, Tuesday, February 16th, 2016
  • Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $154 on, Wednesday, January 20th, 2016

Publication Contributing Sources